[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Coloplast A\u002FS\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":170},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,40,56,84,105,126,145],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100637362","cp384---ostomy-care-oc-pro-panel-plan-100637362",false,"NCT07589907","CP384 - Ostomy Care (OC) PRO Panel Plan","384 PRO Panel","Inclusion Criteria:\n\n* 18 years of age or above\n* full legal capacity\n* willing and able to complete online questionnaires\n* have either an ileostomy, a colostomy, or a urostomy\n\nExclusion Criteria:\n\n* Cannot have a scheduled stoma reversal surgery\n* Cannot have more than one stoma","ALL","18 Years",{"count":19,"type":20},1000,"ESTIMATED","5 Years","OBSERVATIONAL","The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects living with a stoma (ileostomy, colostomy or urostomy).",[25,26,27],"Ostomy","Ileostomy - Stoma","Urostomy","NOT_YET_RECRUITING","2026-05-11",{"date":31,"type":32},"2026-05-15","ACTUAL",{"date":34,"type":20},"2026-06-01",{"date":36,"type":20},"2032-10-31",{"name":38,"class":39},"Coloplast A\u002FS","INDUSTRY",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":47,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":48,"conditions":49,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":51,"startDateStruct":53,"completionDateStruct":54,"leadSponsor":55,"locationsCount":4},"100629499","cp382---intermittent-catheter-ic-pro-panel-plan-100629499","NCT07475468","CP382 - Intermittent Catheter (IC) PRO Panel Plan","382 PRO Panel","Inclusion Criteria:\n\n* Willing to give informed consent\n* 18 years of age or above\n* Full legal capacity\n* Willing and able (self-assessed) to complete online questionnaires\n* using intermittent catheterization as the primary method for bladder emptying",{"count":19,"type":20},"The aim is to create an electronic patient reported outcome (e-PRO) based registry, specifically for subjects using an intermittent catheter as their primary bladder emptying method.",[50],"Intermittent Catheterization",{"date":52,"type":32},"2026-05-13",{"date":34,"type":20},{"date":36,"type":20},{"name":38,"class":39},{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":4,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":63,"targetDuration":4,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":72,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},"100602654","peristeen-light-explorative-clinical-investigation-100602654","NCT07126327","Peristeen Light Explorative Clinical Investigation","An Explorative Clinical Investigation to Understand the Clinical Benefits of Peristeen Light","Inclusion Criteria:\n\n* Has given written informed consent\n* Is at least 18 years old\n* Has full legal capacity\n* Is able (assessed by investigator) and willing to adhere to clinical investigational procedures during clinical investigation-al duration\n* Has access to and is able to use a smartphone\n* Has constipation and\u002For faecal incontinence based on one or more of the following symptoms during the last 3 month: Straining in more than 25% of defecations, lumpy stools (Bristol Stool Type 1 and 2) in more than 25% of defecations, sensation of incomplete evacuation in more than 25% of defecations, sensation of anorectal obstruction\u002Fblockage in more than 25% of defecations, need to use manual maneuvers to facilitate defecation in more than 25% of defecations, fewer than three spontaneous bowel movements per week, loose stools are rarely present without use of laxatives, recurrent uncontrolled passage of faecal material (other words to describe this could be: Soiling, leak-age, passive faecal incontinence of flatus, mucus and\u002For stool)\n* Is assessed (by investigator) to have a need for low-volume TAI minimum every other day\n\nExclusion Criteria:\n\n* Is participating in any other clinical investigation during this investigation\n* Has previously completed this investigation\n* Is former or current user of transanal irrigation (low- and high volume)\n* Has known hypersensitivity towards the device used in the investigation\n* Is pregnant\n* Has known anal stenosis\n* Has active\u002Frecurrent colorectal cancer\n* Has had anastomotic colorectal surgery within the last 3 months\n* Has ischaemic colitis\n* Has active inflammatory bowel disease\n* Has acute diverticulitis or diverticular abscess\n* Has medicine induced constipation (e.g. due to opioids)\n* Has chronic diarrhea\n* Has bowel dysfunction due to neurogenic disorder(s)\n* Is in need of high-volume TAI (as estimated by investigator)",{"count":64,"type":20},60,"INTERVENTIONAL",[67],"NA","The goal of this exploratory clinical investigation is to understand the clinical benefits of Peristeen Light in adult patients with faecal incontinence, chronic constipation and\u002For time-consuming bowel management procedures.\n\nThe primary objective is to evaluate changes in bowel-function when using Peristeen Light. Participants will use Peristeen Light for 12 weeks test period.",[70,71],"Faecal Incontinence","Constipation - Functional",[73],"trans anal irrigation","RECRUITING","2026-04-13",{"date":77,"type":32},"2026-04-14",{"date":79,"type":32},"2025-11-10",{"date":81,"type":20},"2026-08-01",{"name":38,"class":39},2,{"id":85,"slug":86,"hasResults":11,"nctId":87,"briefTitle":88,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":90,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":91,"targetDuration":4,"studyType":65,"phases":93,"briefSummary":94,"conditions":95,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":4},"100622510","exploratory-study-investigating-the-urinary-bladder-during-intermittent-catheterization-in-healthy-and-spinal-cord-injured-male-and-female-subjects-using-an-upright-mri-scanner-100622510","NCT07384559","Exploratory Study Investigating the Urinary Bladder During Intermittent Catheterization in Healthy and Spinal Cord Injured Male and Female Subjects Using an Upright MRI Scanner","Inclusion Criteria:\n\n1. Has given written informed consent\n2. Is at least 18 years old\n3. Has full legal capacity\n4. Is able (assessed by investigator) and willing to adhere to study procedures during study duration\n5. Is able (assessed by investigator) to remain seated in the MRI scanner for minimum 20 minutes\\*\n6. Known with SCI for a minimum of 1 year\\*\n7. Has used IC as primary bladder emptying method for at least 3 months\\* \\* Only for SCI subjects\n\nExclusion Criteria:\n\n1. Is participating in any other clinical investigation during this investigation\n2. Has previously completed this investigation\n3. Has any known allergic or hypersensitive reactions to any device or its ingredients used in the investigation\n4. Is pregnant\n5. Has had surgical procedures performed in the lower urinary tract.\n6. Has active\u002Frecurrent bladder cancer\n7. Has experienced autonomic dysreflexia within the last 2 years\n8. Has any MRI-scanning contraindications, according to MR check list provided by the site (e.g. active implants like pacemaker, cochlear implant, event recorder, implanted insulin pump)\n9. Has symptoms of UTI at times of inclusion, as judged by the investigator.\n10. Has a body weight that exceeds the maximum of 150kg max",true,{"count":92,"type":20},20,[67],"This is an exploratory study investigating morphological and physiological changes of the lower urinary tract and surrounding structures during IC use in individuals with SCI, and during normal voiding and IC use in healthy individuals.",[96],"Retention, Urinary","2026-01-29",{"date":99,"type":32},"2026-02-03",{"date":101,"type":20},"2026-03-02",{"date":103,"type":20},"2026-07-31",{"name":38,"class":39},{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":111,"targetDuration":4,"studyType":65,"phases":113,"briefSummary":114,"conditions":115,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},"100604170","feasibility-of-a-newly-developed-ostomy-prototype-100604170","NCT07146035","Feasibility of a Newly Developed Ostomy Prototype","Inclusion Criteria:\n\nHas given written informed consent Is at least 18 years old Has full legal capacity Is able (assessed by the investigator) and willing to adhere to study procedures during study duration.\n\nHas had an ileostomy for at least 30 days. Has been self-managing their own ostomy product for at least 14 days. Has experienced leakage under the baseplate at least 3 times within the past 2 weeks.\n\nIs able to fit one of the two test product sizes (Ø50mm or Ø60mm). Uses a flat baseplate Is willing to change their baseplate daily Has intact peristomal skin (assessed by the investigator) Is able to use a smartphone with camera\n\nExclusion Criteria:\n\nIs participating in any other clinical investigation during this investigation Has previously participated or completed this investigation Has a known hypersensitivity towards the prototype used in the investigation Is pregnant Is breast feeding Has more than one ostomy synchronously Has ongoing non-healed abdominal wounds Has planned MR scans during the 24-hour test recording",{"count":112,"type":20},10,[67],"Despite the development of better stoma products, individuals with intestinal stomas can experience leakage problems, which negatively affect their quality of life. To overcome this, Coloplast are in the process of developing a leakage measurement device. Each participant will undergo five 24-hour test periods over three weeks, wearing the prototype around the stoma (Test) and on the opposite side (Control).",[116],"Stoma - Ileostomy","2025-08-27",{"date":119,"type":32},"2025-08-28",{"date":121,"type":20},"2025-08-25",{"date":123,"type":20},"2025-09-30",{"name":38,"class":39},1,{"id":127,"slug":128,"hasResults":11,"nctId":129,"briefTitle":130,"officialTitle":130,"acronym":4,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":132,"targetDuration":134,"studyType":22,"phases":4,"briefSummary":135,"conditions":136,"keywords":4,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":125},"100558660","prospective-longitudinal-study-of-heylo-for-people-living-with-a-stoma-100558660","NCT06554015","Prospective Longitudinal Study of Heylo™ for People Living With a Stoma","Inclusion Criteria:\n\n1. Are you at least 18 years old? \\[Yes\u002FNo\\]\n2. Do you have an ileostomy or a colostomy? \\[Yes\u002FNo\\]\n3. Have you used Heylo™ for less than seven days? \\[Yes\u002FNo\\]\n\nExclusion Criteria:\n\n1\\) Do you have a stoma reversal planned (surgery date within the next 6 months)? Yes\u002FNo\\]",{"count":133,"type":20},100,"1 Year","This study aims to longitudinally evaluate the usage and long-term benefits of the CE-marked device, Heylo™, a digital leakage notification system for people with intestinal stomas. The system, which includes a smartphone application, an adhesive sensor layer, and a Bluetooth transmitter, notifies users of changes in their baseplate status, potentially reducing stoma effluent leakage and improving quality of life. The physical Heylo™ device, is part of the Coloplast Charter telehealth service.",[137],"Stoma Ileostomy",{"date":139,"type":32},"2025-09-04",{"date":141,"type":32},"2024-07-01",{"date":143,"type":20},"2027-07-02",{"name":38,"class":39},{"id":146,"slug":147,"hasResults":11,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":4,"eligibilityCriteria":151,"healthyVolunteers":11,"sex":152,"minAge":17,"maxAge":4,"enrollmentInfo":153,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":155,"conditions":156,"keywords":158,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":169},"100370090","a-3-years-naturalistic-cohort-survey-of-virtue-male-sling-system-for-male-stress-urinary-incontinence-100370090","NCT04098822","A 3 Years Naturalistic Cohort Survey Of Virtue® Male Sling System For Male Stress Urinary Incontinence","A 3 Years Naturalistic Cohort Survey Of Virtue® Male Sling System For Male Stress Urinary Incontinence A Post-marketing and Multicenter Prospective Observational Cohort in Subjects With Male Stress Urinary Incontinence","Inclusion Criteria:\n\n* Implanted with the Virtue® Male Sling System\n\nExclusion Criteria:\n\n* Refuses to be included in the survey or that their medical data will be used for research purposes.\n* Indication for the Virtue® Male Sling System implantation is not for the treatment of male urinary incontinence","MALE",{"count":154,"type":20},130,"The purpose of this study is to monitor the use of Virtue® Male Sling in a real world population and collect medical data on effectiveness and to monitor safety of Virtue® at 12 and 36 months post device implantation in men with post-prostatectomy urinary incontinence.",[157],"Urinary Incontinence, Stress",[157,159,160],"Suburethral Slings","Prostatectomy","2023-02-17",{"date":163,"type":32},"2023-02-21",{"date":165,"type":32},"2017-06-29",{"date":167,"type":20},"2026-12",{"name":38,"class":39},13,""]